GFAP and Alzheimer disease: Western blot analyses showed that PEA treatment prevented GFAP increase in primary astrocytes derived from newborn 3×Tg-AD mice in a concentration-dependent manner (P < 0.05) (Figures 3(c) and 3(d)).